Health
Sequencing Study from Roswell Park Highlights Previously Unknown Myeloma Resistance Mechanisms – Newswise
— A group of researchers led by Maximillian Merz, MD, Assistant Professor of Oncology with the Myeloma team at Roswell Park Comprehensive Cancer Center, condu
- First single-cell analysis in a prospective trial for patients with myeloma
- Plasma-cell clones responsible for characteristic bone lesions, team shows
- Findings suggest new strategies for eradicating minimal residual disease
Newswise — BUFFALO, N.Y. — A group of researchers led by Maximillian Merz, MD, Assistant Professor of Oncology with the Myeloma team at Roswell Park Comprehensive Cancer Center, conducted the first prospective clinical trial investigating spatial heterogeneity in patients with either…
Continue Reading
-
General20 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
Business24 hours agoUp 20% in 2 days, are Codan shares a buy, hold or sell?
-
General18 hours agoEveryday AI use brings a hidden climate cost
-
Noosa News23 hours agoBoat crash in Helensvale on the Gold Coast leaves man with life-threatening burns and another one injured